Abraham E. Gracia R.
@Abraham_RMI
MD Internal Medicine @TU_IMSS @HraeZumpango | MSc, PhD candidate @IPN_MX | EB @OxfordMedicalCR | SNI(c) | ORCID: https://t.co/XH0fBur50a
ID:306574437
https://orcid.org/0000-0003-1842-2554 28-05-2011 03:34:52
55,0K Tweets
4,6K Followers
1,9K Following
Follow People
Would love to see a 'spotlight' session on this at ICTMC 2024, or any other work on AI in trials. It would be great to see some of these ideas discussed in a room that also includes experienced trialists and statisticians. ictmc.org/spotlight-sess… cc Mihaela van der Schaar
📡On the spotlight: The man behind “Evidence-Based Medicine”…and so much more (with Gordon H. Guyatt, GRADE Working Group). See the full interview at: medicsvoices.com/gordon-guyatt-…
Buen resumen acerca de los mucroplásticos y lo que se sabe hasta ahora de su impacto en la salud.
Mucho por investigar.
Via Nature Medicine nature.com/articles/s4159…
🧹 Ongoing decontamination… Now RETRACTED: PLOS ONE article featuring #ChatGPT 's “regenerate response” and 18 hallucinated references 😵. Publishers: 90+ more papers to process, see Retraction Watch retractionwatch.com/papers-and-pee… CC Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 CANGARU_checklist x.com/gcabanac/statu…
Thank you to SmartBrief by American Diabetes Association - DiabetesPro for the mention of our study
Mention: sbne.ws/r/PcZk
Full history: medicaldialogues.in/diabetes-endoc…
Article link: sciencedirect.com/science/articl…
The new TRIPOD+AI statement can help guide the writing of research on #artificialintelligence in healthcare to improve the transparency and usefulness of reporting, argues @GScollins TRIPODStatement
bmj.com/content/385/bm…